"Bei Asklepios steht der Mensch im Mittelpunkt. Unsere Mitarbeiterinnen und Mitarbeiter behandeln in unseren Klinken und Lehrkrankenhäusern bundesweit pro Jahr mehr als zwei Millionen Patientinnen und Patienten auf höchstem medizinischen Niveau nach höchsten Qualitätsstandards. Dabei verfolgen wir stets den Anspruch, jeder Patientin und jedem Patienten eine bestmögliche Behandlung in einem jederzeit sicheren Umfeld bei gleichzeitig persönlicher Zuwendung zukommen zulassen. Ob Krankenhaus der Maximalversorgung, spezialisierte Fach- oder Rehaklinik, bei uns werden Sie von hochqualifizierten Fachkräften nach modernsten medizinischen Standards versorgt."

During the past decade, Asklepios Westklinikum Hamburg conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 7 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Asklepios Westklinikum Hamburg" #1 sponsor was "Galapagos NV" with 3 trials, followed by "Shire" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "GWT-TUD GmbH" with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asklepios Westklinikum Hamburg" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Asklepios Kliniken GmbH & Co. KGaA" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Asklepios Westklinikum Hamburg" are "Ulcerative Colitis" (6 trials), "Crohn's Disease" (5 trials), "Colitis, Ulcerative" (2 trials), "COVID-19" (1 trials) and "Chronic Hepatitis B" (1 trials). Many other conditions were trialed in "Asklepios Westklinikum Hamburg" in a lesser frequency.

Most popular intervention types in "Asklepios Westklinikum Hamburg" are "Drug" (16 trials), "Other" (4 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Filgotinib" (4 trials), "Ontamalimab" (2 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Asklepios Westklinikum Hamburg" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Asklepios Westklinikum Hamburg". undefined are not yet recruiting, undefined are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Asklepios Westklinikum Hamburg, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Asklepios Westklinikum Hamburg, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".